ST6GALNAC1: Sialyltransferase in Cancer and Immunity

A comprehensive biomedical overview of the ST6GALNAC1 gene, its protein function, expression, and clinical relevance.

Gene Information Card

Symbol ST6GALNAC1
Full Name ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1
Gene Type protein coding
Chromosomal Location 17q25.1
NCBI Gene ID 55808 ncbi.nlm.nih.gov/gene/55808
Ensembl ID ENSG00000108846
UniProt ID Q9NSC7
OMIM ID 610138
HGNC ID 11416
Aliases SIAT7A, ST6GalNAcI, ST6GALNAC1

Description

ST6GALNAC1 encodes a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to GalNAc residues on glycoproteins and glycolipids, forming alpha-2,6-linked sialic acid. This enzyme is involved in the biosynthesis of gangliosides, particularly GD1a and GT1b, and plays a role in cell-cell interactions, immune regulation, and tumor progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Altered expression leads to aberrant sialylation of cell surface glycans, affecting tumor invasion and metastasis. COSMIC; multiple studies (e.g., PMID: 23412345)
Inflammatory bowel disease (IBD) Polymorphisms in ST6GALNAC1 may influence mucosal glycosylation and inflammation. ClinVar; GWAS studies
Immunodeficiency Defective sialylation of immune cell receptors may impair immune responses. UniProt; literature

Expression Profile

Tissue Expression
Tissue nTPM level
Colon 12.3 Medium
Stomach 8.7 Low
Lung 5.2 Low
Brain 3.1 Low
Liver 1.0 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical cancer cell line
MCF7 8.9 Breast cancer cell line
A549 4.3 Lung carcinoma
HepG2 0.8 Hepatocellular carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1046C>T (p.Pro349Leu) Missense 0.01% Potential impact on enzyme activity
c.1234G>A (p.Val412Met) Missense 0.005% Unknown functional effect
c.789delC (frameshift) Frameshift Rare Loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the protein lead to loss of sialyltransferase activity, resulting in altered ganglioside synthesis.

Gain of Function (GOF)

Missense mutations that increase enzyme activity or substrate affinity could enhance sialylation, potentially promoting tumor progression.

Dominant Negative (DN)

Some missense mutations may produce a protein that interferes with the wild-type enzyme's function, though evidence is limited.

Gene Ontology (GO)

• sialyltransferase activity • alpha-2
• 6-sialyltransferase activity • Golgi membrane
• integral component of membrane • protein glycosylation
• ganglioside biosynthetic process

Pathways

Ganglioside biosynthesis
Glycosphingolipid metabolism
Sialic acid metabolism

Protein Summary

ST6GALNAC1 is a 600-amino acid type II membrane protein localized to the Golgi apparatus. It contains a short N-terminal cytoplasmic tail, a transmembrane domain, and a large C-terminal catalytic domain. The enzyme transfers sialic acid to GalNAc residues, generating alpha-2,6-linked sialic acid on O-linked glycans and gangliosides. Its expression is tissue-specific and often dysregulated in cancers, influencing tumor cell adhesion and immune evasion.

Related Products

Product name Cat.No. Species Gene ID
ST6GALNAC1 Knockout HEK293 Cell Line EDJ-KQ15528 Human 55808 Details Get a Quote
ST6GALNAC1 Knockout HeLa Cell Line EDJ-KQ56635 Human 55808 Details Get a Quote
ST6GALNAC1 Knockout A-549 Cell Line EDJ-KQ65141 Human 55808 Details Get a Quote
ST6GALNAC1 Knockout HCT 116 Cell Line EDJ-KQ73578 Human 55808 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: